Apollomics CFO reports RSU vesting, option grant
Apollomics’ CFO reported vesting of RSUs into shares, share withholding for obligations, and a new stock option grant vesting over one year.
Rhea-AI Filing Summary
Apollomics Inc. (APLM) reported insider equity transactions by Chief Financial Officer and director Peter Kuan-How Lin. On September 15, 2026, 10,000 Restricted Stock Units previously reported vested and were converted into 10,000 Class A Ordinary Shares, and 3,416 of those shares were delivered or withheld to cover exercise price or tax liability.
On September 14, 2026, Lin also received a grant of 6,000 stock options under the Apollomics Inc. 2023 Incentive Award Plan at an exercise price of $23.18 per share. These options vest over one year, with 50% vesting on March 14, 2027 and the remaining 50% on September 14, 2027, subject to continued service. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
10,000 shares exercised/converted
Exercise
4 txns
Insider
LIN PETER KUAN-HOW
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2, F3 | 10,000 | $0.00 | $0.00 |
| Exercise | CLASS A ORDINARY SHARES | 10,000 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | CLASS A ORDINARY SHARES | 3,416 | $24.02 | $82K |
| Grant/Award | Stock option (Right to Buy) F1 | 6,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock option (Right to Buy) — 6,000 contracts (Direct);
Restricted Stock Units — 10,000 contracts (Direct);
CLASS A ORDINARY SHARES — 55,563 shares (Direct)
Footnotes (3)
- F1. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
- F2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
- F3. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 10,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 10,000 RSUs on September 15, 2026.
Key Figures
RSUs vested and converted: 10,000 units / 10,000 shares
Shares delivered or withheld: 3,416 shares
Price for exercise price or tax liability: $24.02 per share
+3 more
6 metrics
RSUs vested and converted
10,000 units / 10,000 shares
Restricted Stock Units vested and converted into Class A Ordinary Shares on September 15, 2026
Shares delivered or withheld
3,416 shares
Shares delivered or withheld for payment of exercise price or tax liability on September 15, 2026
Price for exercise price or tax liability
$24.02 per share
Per-share price associated with delivery or withholding of 3,416 shares
Stock options granted
6,000 options
Stock option grant to CFO on September 14, 2026 under the 2023 Incentive Award Plan
Stock option exercise price
$23.18 per share
Exercise price for 6,000 stock options granted September 14, 2026
Option vesting schedule
50% on March 14, 2027; 50% on September 14, 2027
Vesting of 6,000 stock options, subject to continued service
Key Terms
Restricted Stock Units, Stock option (Right to Buy), Incentive Award Plan, Payment of exercise price or tax liability by delivering or withholding securities
4 terms
Restricted Stock Units financial
"10,000 Restricted Stock Units previously reported vested and were converted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock option (Right to Buy) financial
"The stock option (Right to Buy) was granted under the Apollomics Inc."
Incentive Award Plan financial
"The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan"
An incentive award plan is a formal program that rewards employees, executives, or directors with cash, stock, options, or other pay when the company meets set goals or performance targets. Like a sales commission or a loyalty program that pays out when you hit milestones, it’s designed to align staff behavior with company objectives; investors care because it affects a company’s costs, share count (dilution), leadership incentives, and long-term value creation.
Payment of exercise price or tax liability by delivering or withholding securities financial
"Code F is described as Payment of exercise price or tax liability"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Apollomics (APLM) disclose for its CFO on this Form 4?
Apollomics disclosed that its CFO, Peter Kuan-How Lin, had 10,000 RSUs vest into 10,000 Class A Ordinary Shares, 3,416 shares delivered or withheld to cover exercise price or tax liability, and a grant of 6,000 stock options on September 14–15, 2026.
How many Apollomics (APLM) RSUs vested for the CFO and when?
For Apollomics’ CFO, 10,000 Restricted Stock Units vested on September 15, 2026. Each RSU represents a contingent right to receive one Class A Ordinary Share, and this vesting was part of an RSU grant previously disclosed on Forms 3 and 3/A.
What stock options did the Apollomics (APLM) CFO receive and at what exercise price?
On September 14, 2026, the Apollomics CFO received a grant of 6,000 stock options with an exercise price of $23.18 per share, each option covering one Class A Ordinary Share, under the Apollomics Inc. 2023 Incentive Award Plan.
What is the vesting schedule for the new Apollomics (APLM) stock options granted to the CFO?
The 6,000 stock options granted on September 14, 2026 vest over one year: 50% of the shares vest on March 14, 2027, and the remaining 50% vest on September 14, 2027, subject to the CFO’s continued service to Apollomics through each vesting date.
Were the Apollomics (APLM) CFO’s Form 4 transactions made under a Rule 10b5-1 plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not marked, and there is no footnote stating that these transactions were made under a Rule 10b5-1 trading plan or similar pre-arranged trading arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
